Johannes Czernin

University of California, Los Angeles — United States

Medicine · Health Sciences

23h-index2.9kcitations96works5.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(35), Prostate Cancer Treatment and Research(28), Radiopharmaceutical Chemistry and Applications(26), Radiomics and Machine Learning in Medical Imaging(23), Prostate Cancer Diagnosis and Treatment(8)

Publications96 total

Making a Career to Fight Cancer
Journal of Nuclear Medicine·2025
<sup>177</sup> Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
Journal of Clinical Oncology·2025· 3 citedOpen Access
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance
Signal Transduction and Targeted Therapy·2025· 1 citedOpen Access
Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with <sup>177</sup> Lu-PSMA: A Retrospective, Single-Center Study
Journal of Nuclear Medicine·2025· 1 cited
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of <sup>177</sup>Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol
Journal of Nuclear Medicine·2025· 1 citedOpen Access
Precision Medicine Is Critical for the Future of Oncology
Journal of Nuclear Medicine·2025· 1 citedOpen Access
LRRC15-radioimmunotheranostics: Targeting TGFβ-driven resistance in immune-excluded solid tumors.
Journal of Clinical Oncology·2025
Studienprotokoll der laufenden FLEX-MRT Studie: Randomisierte Phase-2-Studie zur FLEXiblen und erweiterten Dosierung der [177Lu]Lu-PSMA-617 Molekularen RadioTherapie (FLEX-MRT) in Patienten mit mCRPC
Nuklearmedizin - NuclearMedicine·2025
A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source software
Methods·2025· 2 cited
Abstract P005: Fibroblast Activation Protein (FAP)-targeted radioligand therapy as a promising treatment for glioblastoma
Clinical Cancer Research·2025
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
JAMA Network Open·2025· 46 citedOpen Access
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study
Journal of Nuclear Medicine·2025· 18 citedOpen Access
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
Journal of Nuclear Medicine·2024· 7 citedOpen Access
Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI
Journal of Nuclear Medicine·2024· 2 citedOpen Access
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy
Scientific Reports·2024· 7 citedOpen Access
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Journal of Nuclear Medicine·2024· 14 citedOpen Access
A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2024Open Access
Phase 2 Prospective Trial of Re-Treatment with177 lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA): Study Protocol
International Journal of Radiation Oncology*Biology*Physics·2024· 1 citedOpen Access
Clinical Factors That Influence Repeat<sup>68</sup>Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative<sup>68</sup>Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study
Journal of Nuclear Medicine·2024· 3 citedOpen Access
Exploring the prognostic value of the TRAQinform Profile applied to end-of-treatment PSMA PET/CT in patients with mCRPC and treated with <sup>177</sup>Lu-PSMA radioligand therapy: A retrospective, single-center analysis.
Journal of Clinical Oncology·2024
page 1 of 5Next →

Frequent Co-authors

Jérémie Calais(17), Magnus Dahlbom(10), Michael E. Phelps(8), Daniel Silverman(7), Masatoshi Hotta(6), Martin Allen-Auerbach(5), Wesley R. Armstrong(5), Matthew B. Rettig(5), Matthias Benz(4), Adam Kesner(4), Michael E. Phelps(4), Thomas A. Hope(4), Wolfgang P. Fendler(4), Tristan Grogan(4), Christiaan Schiepers(3), Nicholas G. Nickols(3), Andrei Gafita(3), Ida Sonni(3), Carl K. Hoh(2), Caius G. Radu(2)